The Value of Extracellular Volume (ECV) in ATTR - Transthyretin Amyloidosis

Cardiac MRI is a useful tool to diagnose amyloidosis. T1 mapping has become a mainstay, both native and ECV measurements. ECV measurement can now help quantify the amyloidosis burden and may help guide treatment based on how the ECV responds to specific treatment measures.

The Value of Extracellular Volume (ECV) in ATTR - Transthyretin Amyloidosis

83-years old presented with HFrEF in June 2025, echo showing LVH with reduced EF.

Cardiac MRI shows typical findings of amyloidosis with diffuse transmural enhancement, deranged contrast kinetics and raised T1 and an ECV of 60%.

The video discusses the case and the importance of T1 and ECV, specifically based on a new JACC article that I read yesterday (Sheikh A et al - JACC 2026 Vol 87, pg 505), published a day prio that discusses the importance of ECV in quantifying transthyretin amyloidosis.

To know each time a new post is up

To Subscribe

Video

This adds to other similar posts

Other Amyloidosis Cases

Looking at the Heart On Every Cross-Sectional Thoracic Study
It is not just cardiac MRI and cardiac CT that give us clues to a cardiac pathology. We should look at the heart on any cross-sectional thoracic study.
Cardiac amyloidosis
Case based learning of Cardiac MRI

Previous Post

COD 158 - Septum Predominant HCM and RVoTo
RVoTo involvement in HCM is uncommon but diagnosing it may change the management plan and prognosis